Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	58.45	37.79	38.52	54.84
Short-Term Investments	177.43	109.75	-	27.77
Cash & Short-Term Investments	235.88	147.54	38.52	82.61
Cash Growth	59.88%	283.01%	-53.37%	-
Other Current Assets	5.54	3.46	0.69	1.22
Total Current Assets	241.42	150.99	39.21	83.83
Net Property, Plant & Equipment	9.15	10.3	11.73	2.57
Long-Term Investments	74.42	20.51	-	-
Other Long-Term Assets	0.96	3.96	1.01	1.01
Total Assets	325.95	185.75	51.95	87.37
Accounts Payable	0.77	1.19	0.72	0.56
Accrued Expenses	9.67	8.16	6.59	7.7
Current Portion of Leases	1.27	1.07	0.73	-
Total Current Liabilities	11.71	10.42	8.04	8.25
Long-Term Leases	7.41	8.68	9.75	-
Total Long-Term Liabilities	7.41	8.68	9.75	-
Total Liabilities	19.12	19.1	17.79	8.25
Common Stock	0.05	0.01	0	0
Additional Paid-in Capital	562.6	17	4.52	2.23
Accumulated Other Comprehensive Income	0.54	0.37	-	-0.02
Retained Earnings	-256.35	-181.09	-119.4	-72.14
Total Common Shareholders' Equity	306.83	-163.71	-114.88	-69.92
Minority Interest	-	330.37	149.04	149.04
Shareholders' Equity	306.83	166.66	34.16	79.12
Total Liabilities & Equity	325.95	185.75	51.95	87.37
Total Debt	8.68	9.75	10.48	0
Net Cash (Debt)	227.21	137.79	28.04	82.61
Net Cash Growth	64.89%	391.33%	-66.05%	-
Net Cash Per Share	5.69	35.71	9.56	0.03
Book Value	306.83	-163.71	-114.88	-69.92
Book Value Per Share	7.68	-42.43	-39.17	-0.03
Tangible Book Value	306.83	-163.71	-114.88	-69.92
Tangible Book Value Per Share	7.68	-42.43	-39.17	-0.03

Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q